Navigation Links
Luckey & Mullins Joins with Other National Construction Defect Law Firms to Form Chinese Drywall Legal Network
Date:12/11/2009

Mississippi-based law firm helps create joint venture group with five other firms to form "Dream Team" of plaintiffs' attorneys handling defective construction litigation

Ocean Spring, Miss. (Lexis Nexis) December 11, 2009 -- Luckey & Mullins, a Gulf Coast law firm that represents plaintiffs in a wide range of personal injury, construction defect, products liability and toxic mold cases, has joined forces with five other highly regarded law firms to form the Chinese Drywall Legal Network.

This unique joint venture group is made up of a diverse team of expert attorneys with a combined 150 years of experience in handling the complex legal issues that arise in disputes involving defective construction products, such as Chinese drywall. In addition to Ocean Spring, Miss.-based Luckey & Mullins, The Chinese Drywall Legal Network includes law firms with offices in Florida, Louisiana, New Jersey, North Carolina and Washington, D.C.

In the aftermath of Hurricane Katrina in 2005, there was a serious shortage of domestic drywall needed in the construction of new housing units. In response, U.S. distributors began importing large amounts of drywall from China, which was never adequately tested or inspected. It has now been found to contain significant amounts of sulfur and sulfur-related compounds and other impurities. In addition to a variety of structural problems that these compounds can cause to a house, homeowners have also been reporting physical ailments, including coughing, irritated eyes, sneezing, sore throat, difficulty breathing, bloody noses and headaches after being exposed to the problematic Chinese drywall.

"Our team of experienced and well-respected lawyers has successfully represented thousands of homeowners in other defective construction litigation cases, often winning multimillion-dollar verdicts and settlements for our clients," said Steve Mullins, partner in Luckey & Mullins. "We are heavily involved in the multidistrict litigation Chinese drywall action in New Orleans right now and the attorneys in our network hold many key positions and are either co-chairs or members of 17 committees that have been formed to help streamline Chinese drywall cases through the courts. We are at the leading edge of this litigation and have access to the latest court decisions, experts and case strategies for helping consumers who have claims they wish to pursue."

According to Mullins, significantly more than 500 million pounds of Chinese drywall was imported into the U.S. and up to 100,000 homes, condos, and apartment units likely contain the problematic Chinese drywall right now. "We are at the tip of the iceberg right now," Mullins said, "and all we are sure of at this time is that this is the most significant construction defect problem to ever face this nation and the consequences of how we deal with it will be both far reaching and long lasting."

For more information about Luckey & Mullins, please go to www.luckeyandmullins.com or call 800.874.3175.

###

Read the full story at http://www.prweb.com/releases/2009/12/prweb3322664.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Get Your Fruits & Veggies: CDC
2. Mount Sinai & ENT and Allergy Associates, LLP affiliate to fight cancer
3. Story ideas from molecular & cellular proteomics
4. Job picture for 2006 chemistry grads reasonably good, C&EN reports
5. Debut issue of Foot & Ankle Specialist
6. Congressional R&D Caucus co-chairs join scientists, engineers and graduate students
7. IU Health & Wellness: Research and insights from Indiana University
8. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
9. European Society of Human Reproduction & Embryology 24th annual meeting
10. IU Health & Wellness: New research findings from the Kinsey Institute
11. Riley Hospital for Children & Capital Institute of Pediatrics become international sister hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/26/2017)... ... ... Millennium”: a gripping take on how the author used personal experience to strengthen the ... do not affect daily choices. It shows how to act like the heirs of ... chosen. “How to Live in the Millennium” is the creation of published author, Gina ...
(Date:9/26/2017)... ... September 26, 2017 , ... “Sonflower Submission”: a ... nature to the inevitable destinations of negativity, complaining and the need to always be ... take effect in order for a lesson in stress-less living to be learned. ...
(Date:9/25/2017)... ... September 26, 2017 , ... Your World Insurance Services, a long-time ... began fulfilling a life-long wish of owner Stacy Boyle to give back to the ... help when I was in high school,” said Ms. Boyle. “My father passed away ...
(Date:9/25/2017)... ... September 25, 2017 , ... SyncDog, ... release of SentinelSecure™, version 3.0, will be available in a managed cloud services ... of SentinelSecure™ comes with several new enhancements including support for caller ID and ...
(Date:9/25/2017)... ... September 25, 2017 , ... The Byron Eaton Agency, a Birmingham based ... region, is organizing a local charity drive to send money and support to families ... of water have fallen on Houston as a result of Hurricane Harvey, raising water ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... BioLife Solutions , Inc. (NASDAQ: BLFS ), the ... and tissue hypothermic storage and cryopreservation freeze ... and CEO, will be presenting at two investment conferences in ... th Annual Global Investment Conference on Tuesday, September 12th, ... conference is being held at the New York Palace Hotel ...
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly and ... will present new data for galcanezumab and lasmiditan, two ... the International Headache Society (IHC) taking place Sept. 7-10 ... Lilly will highlight new, long-term data from an open-label ... of galcanezumab (120 mg and 240 mg) for the ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... a clinical-stage pharmaceutical company focused on the development of ... successfully concluded its meeting with the U.S. Food and ... insulin formulation. At ... regulatory pathway for submission of ORMD-0801, would be a ...
Breaking Medicine Technology: